Balanced news tone
News Sentiment
NOVN sentiment intelligence
Novartis AG news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
53
Balanced news tone
39 relevant articles
News tone and price action are not far from neutral.
80/100 classification confidence.
directly relevant articles
high-authority source matches
-2.8% over one week, +1.8% over four weeks, trend active, and materially above fair value.
Novartis (SWX:NOVN) Stock Looks Below Fair Value Despite An 88% Run
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
80/100 classification
One-week reaction
-2.8%
Price reacting lower
Trend fit
Trend active
1.8% over four weeks
Fair value
33.0%
Materially above fair value
Sentiment Mix
Positive, neutral, negative
Positive
9
Neutral
28
Negative
2
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Market source
Direct company coverage
Novartis (SWX:NOVN) Stock Looks Below Fair Value Despite An 88% Run
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jul 2026 18:11
- Source
- Market source
simplywall.st
Direct company coverage
Is Novartis (SWX:NOVN) Undervalued As EU Expands Approval For Its Gene Therapy?
- Tone
- Positive 66/100
- Event
- Regulatory and legal
- Published
- 17 Jul 2026 05:45
- Source
- simplywall.st
ad-hoc-news.de
Direct company coverage
Novartis stock holds steady on its global drug pipeline
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 18:14
- Source
- ad-hoc-news.de
ad-hoc-news.de
Direct company coverage
Novartis stock. Generalized update on the Swiss drugmaker.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 05:05
- Source
- ad-hoc-news.de
Market source
Direct company coverage
Novartis (SWX:NOVN) Stock Looks Cheap on Value But Pricey After 93% Return
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Novartis (SWX:NOVN) Wins EU Approval For Itvisma In A Broader SMA Market
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 03 Jul 2026 07:00
- Source
- Market source
simplywall.st
Direct company coverage
Is Novartis (SWX:NOVN) Fully Valued On Its Pipeline And Margin Growth Story?
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 25 Jun 2026 07:00
- Source
- simplywall.st
Market source
Direct company coverage
Novartis AG (NVS): 7 Best Longevity and Anti-Aging Stocks to Buy
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Market source
ad-hoc-news.de
Direct company coverage
Novartis AG Stock (CH0012005267): Analyst Targets and SMI Role Keep Shares in Focus
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 16 Jun 2026 07:00
- Source
- ad-hoc-news.de
ad-hoc-news.de
Direct company coverage
Novartis AG Stock (CH0012005267): In focus on a quiet Sunday session
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jun 2026 07:00
- Source
- ad-hoc-news.de
Market source
Direct company coverage
Assessing Novartis (SWX:NOVN) Valuation After A Strong Year Of Total Shareholder Returns
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 10 Jun 2026 07:00
- Source
- Market source
TradingKey
Direct company coverage
Novartis AG Stock (NVS) Moved Down by 3.14% on Jun 1: Key Drivers Unveiled
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- TradingKey
ad-hoc-news.de
Direct company coverage
Novartis AG stock (CH0012005267): valuation metrics in focus after recent share price consolidation
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 May 2026 07:00
- Source
- ad-hoc-news.de
ad-hoc-news.de
Direct company coverage
Novartis AG stock (CH0012005267): shares little changed as investors digest Swiss pharma group’s s
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 May 2026 07:00
- Source
- ad-hoc-news.de
ad-hoc-news.de
Direct company coverage
Novartis AG stock (CH0012005267): Spin-off, oncology focus and pipeline updates in the spotlight
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 May 2026 07:00
- Source
- ad-hoc-news.de
ad-hoc-news.de
Direct company coverage
Novartis AG stock (CH0012005267): pipeline progress and steady demand keep pharma giant in focus
- Tone
- Neutral 50/100
- Event
- Macro sensitivity
- Published
- 24 May 2026 07:00
- Source
- ad-hoc-news.de
ad-hoc-news.de
Direct company coverage
Novartis stock (CH0012005267): U.S. drug pipeline and recent catalyst watch
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 May 2026 07:00
- Source
- ad-hoc-news.de
Market source
Direct company coverage
Novartis (SWX:NOVN) Valuation Check After New Pluvicto PSMAddition Study Data And Regulatory Filings
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 19 May 2026 07:00
- Source
- Market source
ad-hoc-news.de
Direct company coverage
Novartis AG stock (CH0012005267): dividend profile and pipeline focus move into the spotlight
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 16 May 2026 07:00
- Source
- ad-hoc-news.de
ad-hoc-news.de
Direct company coverage
Novartis stock (CH0012005267): Q1 2026 earnings show blockbuster growth amid patent headwinds
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 12 May 2026 07:00
- Source
- ad-hoc-news.de
ad-hoc-news.de
Direct company coverage
Novartis AG stock (CH0012005267): Mixed Q1 2026 results across pharma peers highlight sector dynamic
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 May 2026 07:00
- Source
- ad-hoc-news.de
ad-hoc-news.de
Direct company coverage
Novartis AG stock (CH0012005267): Global pharma leader navigates patent cliffs
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 May 2026 07:00
- Source
- ad-hoc-news.de
Market source
Direct company coverage
Is It Too Late To Consider Novartis (SWX:NOVN) After Its Strong 1-Year Share Price Run?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 10 May 2026 07:00
- Source
- Market source
ad-hoc-news.de
Direct company coverage
Novartis AG stock (CH0012005267): Q1 2026 results miss EPS consensus as revenue dips slightly year?o
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 08 May 2026 07:00
- Source
- ad-hoc-news.de
simplywall.st
Direct company coverage
Is It Too Late To Consider Novartis (SWX:NOVN) After Its 3 Year 41.9% Rise?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 May 2026 07:00
- Source
- simplywall.st
Market source
Direct company coverage
Here's What Analysts Are Forecasting For Novartis AG (VTX:NOVN) After Its First-Quarter Results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 01 May 2026 07:00
- Source
- Market source
GuruFocus
Direct company coverage
Novartis AG (NVS) Stock Up 3.4% but GF Value Says Overvalued -- GF Score: 83/100
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Apr 2026 07:00
- Source
- GuruFocus
Market source
Direct company coverage
Is It Too Late To Consider Novartis (SWX:NOVN) After Its 30% One-Year Rally?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Assessing Novartis (SWX:NOVN) Valuation After Recent Share Price Moves And Long Term Returns
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Assessing Novartis (SWX:NOVN) Valuation After Recent Mixed Share Price Performance
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Mar 2026 07:00
- Source
- Market source